Fingerprint
Dive into the research topics of 'Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Olaf Stuve
Research output: Contribution to journal › Article › peer-review
23
Scopus
citations